NS5A Inhibitors

J&J snaps up an NS5A inhibitor from GlaxoSmithKline for hep C cocktail
Fierce Biotech
Tue, 10/8/13 - 09:41 am
JNJ
NS5A Inhibitors
GSK
hepatitis C
simeprevir
GSK2336805
Why A Change In A Bristol-Myers Hepatitis C Trial Has Big Implications
Forbes
Fri, 06/29/12 - 09:25 am
hepatitis C
Bristol-Myers Squibb
Gilead
NS5A Inhibitors
daclatasvir
Bristol Hep C Trial Change Has Big Implications
Pharmalot
Wed, 06/20/12 - 12:31 pm
hepatitis C
Bristol-Myers Squibb
clinical trials
Gilead
NS5A Inhibitors
declatasvir
Presidio Pharmaceuticals, Inc. Announces Clinical Proof-of-Concept Data for its First HCV NS5A Inhibitor, PPI-461, and Initiation of Clinical Testing for its Second-Generation NS5A Inhibitor, PPI-668.
BusinessWire
Sun, 11/6/11 - 12:19 pm
NS5A Inhibitors
PPI-461
PPI-668
HCV